All In MedTech

Device Trial Radar · NCT05777759

Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

Last checked: Nov 20, 2026Latest source record: May 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 175 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

175

Actual

Start

Mar 22, 2023

Primary completion

Nov 11, 2023

Study completion Jul 10, 2024

Sponsor

Lead sponsor
Galderma R&DNot on our public-company list
Sponsor type
Industry
First posted
Mar 21, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The primary objective of the study was to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.

Conditions

  • Chin Augmentation
  • Chin Retrusion

Interventions

  • Restylane Lyft with LidocaineDevice

    hyaluronic acid

  • Juvederm Voluma XCDevice

    hyaluronic acid

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in the Blinded Evaluators' Live Assessment Using the Galderma Chin Retrusion Scale (GCRS) at Month 3Time frame: Baseline (last non-missing observation prior to the first administration of study product) and Month 3

Locations

12 sites in 2 countries. Site status is shown where the registry gives one.

  • Galderma Research Site

    Los Angeles, California

11 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.